In HCC, NEIL3 not only repairs telomeric oxidative damage to delay cellular senescence but also activates the BRAF/MEK/ERK/TWIST pathway to induce core stemness phenotypes including epithelial-mesenchymal transition, therapy resistance, and enhanced self-renewal (56). Here, MAP2K7 is linked to hepatocellular carcinoma.